ALT normality rate in chronic hepatitis group is higher than that in cirrhosis group at 4 weeks of treatment (89.7% versus 60.0%, p < 0.05) and at 12 weeks after EOT (94.9% versus 66.7%, p < 0.05) in our study. The gene discussed is GPT; the disease is chronic hepatitis.